Showing results (141-150 of 1,402) with videos related to
Sort By:
Pageof 141
The Journal of Sexual Medicine|January 18, 2012
A review of surgical techniques for impending distal erosion and intraoperative penile implant complications: part 2 of a three-part review series on penile prosthetic surgeryGerard D Henry, Eric LabordeCirculation Research|October 1, 1979
Sensitization of isolated canine coronary arteries to calcium ions after exposure to cholesterolM Yokoyama, P D HenryCatheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 21, 2016
Don't you forget about me! The 80s still matter!Justin Cox, Timothy D HenryJournal of Medicinal Chemistry|April 26, 2000
Binding of norbinaltorphimine (norBNI) congeners to wild-type and mutant mu and kappa opioid receptors: molecular recognition loci for the pharmacophore and address components of kappa antagonistsD L Larson, R M Jones, S A Hjorth, et al.Journal of Medicinal Chemistry|February 1, 1979
Synthesis and pharmacologic characterization of an alkylating analogue (chlornaltrexamine) of naltrexone with ultralong-lasting narcotic antagonist propertiesP S Portoghese, D L Larson, J B Jiang, et al.International Advances in Surgical Oncology|January 1, 1981
Prolatin secreting pituitary adenomasM E Leavens, N A Samaan, D L Larson, et al.European Journal of Pharmacology|January 8, 1985
Opioid receptor binding characteristics of the non-equilibrium mu antagonist, beta-funaltrexamine (beta-FNA)S J Ward, D S Fries, D L Larson, et al.The Cleft Palate Journal|April 1, 1980
Nasal obstruction as a complication of pharyngeal flap surgeryJ B Thurston, D L Larson, J C Shanks, et al.Journal of Medicinal Chemistry|September 1, 1983
Importance of C-6 chirality in conferring irreversible opioid antagonism to naltrexone-derived affinity labelsL M Sayre, D L Larson, D S Fries, et al.Pageof 141